KMB · NASDAQ · STOCK
Kimberly-Clark (KMB) Stock Analysis
$111.37
52W $92.42 – $131.53
50/100
$36.97B
18.9
0.28
Is KMB Bullish or Bearish?
Mixed.
Innellis AI committee rates Kimberly-Clark Corporation (KMB) Watch with a composite score of 50/100
, based on 6 analysts with 33% agreement.
Last updated August 25, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.59 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.41 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.33 across 26 articles, 14d). Risk Analyst remains cautious — high leverage (debt-to-equity 4.79) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 122.6% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.9% pays you to wait — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- News sentiment is positive (+0.33 across 26 articles, 14d) — News
Bear Case
- Price-to-book of 22.3x prices in significant intangible value — Value
- Debt-to-equity of 4.79 adds balance-sheet risk to the value case — Value
- Revenue declining -12.2% YoY -- this is not a growth story right now — Growth
- EPS declining -19.1% YoY despite any revenue growth — Growth
- MACD histogram negative -- bearish momentum — Technical
- High leverage (debt-to-equity 4.79) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 25, 2026
Overall Committee Score
50/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 93%
of 72 Consumer Defensive peers
Value Analyst
neutral
50
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 122.6% shows genuine earnings power backing the valuation
− Price-to-book of 22.3x prices in significant intangible value
Growth Analyst
bearish
38
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ 4 consecutive earnings beats -- consistent execution
− Revenue declining -12.2% YoY -- this is not a growth story right now
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 4.79) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 26 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3063.01)
Investment Thesis Evolution
Committee score moved marginally from 50.4 to 50.4.
Comparing 2026-08-24 to 2026-08-25 (1 day apart).
Technical Analysis
RSI (14)
60.0
Neutral
MACD Histogram
-0.044
Bearish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Lh Ll
Support
$99.28
Resistance
$111.78
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$109.60
Above
EMA 21
$109.44
Above
EMA 50
$107.89
Above
EMA 200
$107.62
Above
Fundamental Analysis
Valuation
61
Growth
78
Profitability
75
Financial Health
5
Cash Flow
70
Valuation
P/E Ratio
18.9×
P/B Ratio
21.17×
PEG Ratio
-0.98
Dividend Yield
4.56%
52W High
$131.53
52W Low
$92.42
Quality & Growth
ROE
13455.4%
ROA
1173.2%
Gross Margin
3669.2%
Operating Margin
1238.2%
Revenue Growth YoY
—
Debt / Equity
3.72
AI Fundamental Assessment
P/E ratio of 18.9 (inexpensive relative to a 15-40x range); Price-to-book of 21.2x; PEG ratio of -1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 134.6%; Return on assets of 11.7%; Net margin of 11.8%; Gross margin of 36.7%; Current ratio of 0.91 (tight short-term liquidity); Debt-to-equity of 3.72; Free cash flow per share is positive (7.70); Most recent quarter beat estimates by 4.2%; 4 consecutive earnings beats; EPS growth roughly steady (+5.9% -> +7.6% QoQ); Average YoY EPS growth of 30.1%; Analyst estimates rising over recent quarters
Get the Full KMB Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →